Revolutionizing Airport Safety: Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program
Public-Private Partnership for Innovative Travel Biosecurity Ginkgo Bioworks and XpresSpa Group Team up to Support CDC’s SARS-CoV-2 Initiative In a groundbreaking collaboration, Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) have joined forces to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurity. This partnership aims…